| Approved on: | 2022-12-13 |
| Brief purpose of the study: | The purpose of the study is to learn more about the effects of the COVID-19 bivalent booster in pregnant and breastfeeding women, along with their infants. |
| Brief summary of what participants will be asked to do: | Mothers are being asked to provide up to 12 blood samples (6 during pregnancy and 6 postpartum), their placenta, and 6 breastmilk samples. The infant is being asked to provide 6 blood samples (after birth). Samples will be collected over the course of up to 12 months. |
| Basic eligibility criteria: | Inclusion Criteria:
- Pregnant women (18-50 years of age) who plan to breastfeed;
- Do not have anemia (determined from first blood draw);
- English-speaking; and
- Have already received a COVID-19 vaccine and are planning on receiving a COVID-19 bivalent booster during pregnancy
- Infants of mothers in this study |
| Study contact for more information: | Research team at pregstudy@missouri.edu |
| IRB Number: | 2094356 MU |
